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Abstract
Background: The Integrated eDiagnosis Approach (IeDA), centred on an electronic Clinical Decision Support
System (eCDSS) developed in line with national Integrated Management of Childhood Illness (IMCI) guidelines, was
implemented in primary health facilities of two regions of Burkina Faso. An evaluation was performed using a
stepped-wedge cluster randomised design with the aim of determining whether the IeDA intervention increased
Health Care Workers’ (HCW) adherence to the IMCI guidelines.
Methods: Ten randomly selected facilities per district were visited at each step by two trained nurses: One
observed under-five consultations and the second conducted a repeat consultation. The primary outcomes were:
overall adherence to clinical assessment tasks; overall correct classification ignoring the severity of the classifications;
and overall correct prescription according to HCWs’ classifications. Statistical comparisons between trial arms were
performed on cluster/step-level summaries.
Results: On average, 54 and 79% of clinical assessment tasks were observed to be completed by HCWs in the
control and intervention districts respectively (cluster-level mean difference = 29.9%; P-value = 0.002). The proportion
of children for whom the validation nurses and the HCWs recorded the same classifications (ignoring the severity)
was 73 and 79% in the control and intervention districts respectively (cluster-level mean difference = 10.1%; P-
value = 0.004). The proportion of children who received correct prescriptions in accordance with HCWs’
classifications were similar across arms, 78% in the control arm and 77% in the intervention arm (cluster-level mean
difference = − 1.1%; P-value = 0.788).
Conclusion: The IeDA intervention improved substantially HCWs’ adherence to IMCI’s clinical assessment tasks,
leading to some overall increase in correct classifications but to no overall improvement in correct prescriptions.
The largest improvements tended to be observed for less common conditions. For more common conditions,
HCWs in the control districts performed relatively well, thus limiting the scope to detect an overall impact.
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Background
Currently, more than 75 low- and middle-income coun-
tries (LMIC) are implementing the Integrated Manage-
ment of Childhood Illness (IMCI) strategy on a large
scale. However, poor adherence of health care workers
(HCWs) to guidelines has often been reported [1, 2],
likely due to health system limitations, such as lack of
training, coordination and supervision, or low availability
of essential medicines and equipment [3–6]. In Burkina
Faso, the IMCI strategy was introduced in 2003, but an
evaluation conducted in 2011 reported a low coverage of
training and poor performance in terms of adherence to
guidelines [7].
Recent advances in Information and Communication
Technologies (ICT) and the advent of electronic Clinical
Decision Support System (eCDSS) could potentially
transform health care services in LMICs, for instance by
helping HCWs to correctly follow relatively complex
charts. However, several reviews reveal the lack of
evidence for a scalable and sustainable impact on health
indicators [8–12]. In particular, the experience with
using such technology to improve adherence to the
IMCI guidelines is limited [13–17].
From 2014, Terre des hommes foundation (Tdh), in
partnership with the Burkinabe Ministry of Health
(MoH), implemented, in primary health facilities of two
regions of Burkina Faso, the Integrated eDIagnosis Ap-
proach (IeDA), a complex intervention centred on an
eCDSS developed in line with national IMCI guidelines,
with the objective of improving HCWs’ adherence to the
IMCI guidelines. Between 2014 and 2017, an evaluation
was performed using a stepped-wedge cluster rando-
mised design by an independent team from the London
School of Hygiene and Tropical Medicine (LSHTM),
United Kingdom, and Centre Muraz, Burkina Faso. The
aim of the evaluation was to determine whether the
IeDA intervention increased adherence to the IMCI
guidelines and improved clinical assessment, classifica-
tion, prescription, referral and counselling during under-
five child consultations in primary health facilities.
Methods
Setting
In Burkina Faso, coverage of key effective interventions
for preventing child deaths has steadily increased follow-
ing the adoption of successive public health policies (e.g.
free anenatal care, subsidies for child birth and
emergency obstetric care, national distribution of in-
secticide treated nets, Artemisinin-based Combination
Therapy (ACT) for treating uncomplicated malaria at
facility and community level, expanded program for vac-
cination). Consequenttly, in 2015, the under-five mortal-
ity rate had declined by 56% compared to 1990, from an
estimated 202 deaths per 1000 live births in 1990 to 89
deaths per 1000 live births in 2015 [18]. The government
is the main health service provider and managed 83% of
facilities within the country in 2014 [19]. The country is
divided into 13 regions further subdivided into 63 health
districts each with one district or regional hospital. In
rural areas, primary health facilities, usually run by one
or more nurses with the support of health assistants, are
the most common point of care and provide a basic
package of outpatient services. In 2014, there were 1824
primary health facilities, corresponding to about one fa-
cility per 10,000 inhabitants.
The evaluation took place in the Boucle du Mouhoun
and Nord regions from September 2014 to November
2017. Of the 11 districts in these two regions, three
districts were selected by the implementing agencies to
pilot the first versions of the eCDSS in 2010 and were
therefore excluded from the evaluation, which was
restricted to the eight remaining districts (Fig. 1). In
addition to IeDA, a performance-based financing (PBF)
intervention was independently implemented in four
trial districts (Nouna, Solenzo, Gourcy and Ouahigouya
districts). From April 2016, free care for under-five
children was also introduced by the MoH in all public
facilities [20].
The IeDA intervention
The IeDA intervention comprised five components: 1.
An eCDSS provided on tablets to primary health facil-
ities for the management of under-five connsultations:
Based on the information recorded by HCWs from the
clinical assessment of the child (e.g. body temperature),
the eCDSS displays the relevant charts on the screen to
guide HCWs through the IMCI national protocol, from
the classification (e.g. uncomplicated malaria), through
prescription (e.g. first line antimalarial), referral and
counselling. During the trial period, several versions
were deployed following feedback from users and stake-
holders; 2. A six-day training course provided to HCWs
on IMCI guidelines and the use of the eCDSS. During
the last year of the trial, learning modules with short
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videos were also available on the eCDSS to support
continuous training; 3. A quality assurance coaching sys-
tem involving team meetings two to four times a year
through which health district authorities and HCWs dis-
cussed solutions to their local issues (e.g. organisation of
care); 4. A supervision system including monthly visits
to primary health facilities; 5. A health information sys-
tem based on data collected through the eCDSS. During
the last year of the trial, descriptive dashboards on
under-five consultations were developed and shared with
the health district authorities and HCWs.
Evaluation design
Since some components of the intervention could only
be delivered at the district level, and rolling out the
intervention in a phased manner was more practical for
the implementing agencies, the evaluation used a
stepped-wedge cluster randomised design, with health
districts (“clusters”) receiving the intervention at differ-
ent time points in a randomised order.
Nine steps, one every 4 months, were initially planned,
with the first step used as baseline (Fig. 2a). However,
funding and logistic issues resulted into delayed roll-out
and only four out of eight districts with the intervention
implemented. The baseline phase included the first two
steps, and during each of the next four steps, from step 3
to step 6, a new district implemented the intervention
(Fig. 2b). For the purposes of data collection, ten primary
facilities with staff trained in IMCI were randomly selected
in each district with stratification on the 2013 annual
under-five consultations caseload [21]. Eight rounds of
data collection were conducted in total (Fig. 2b).
Full implementation in a district was considered to
have been achieved when the eCDSS was provided to
all primary facilities and when all HCWs had been
trained in its use and IMCI guidelines. In some con-
trol districts, data were collected after implementation
started but before the full implementation was com-
pleted, resulting in some “contamination” of these
control districts (Fig. 2b).
Fig. 1 Eight health districts included in the trial. Blue and red circles indicate control and intervention districts respectively. Source: Burkina Faso,
Map No. 4230, November 2004, UNITED NATIONS
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Randomisation and masking
Randomisation was restricted to ensure intervention and
control clusters were balanced with respect to region
and the PBF intervention. Details of the randomisation
procedure used to allocate districts to receive the
intervention have been published elsewhere [21].
Randomization was performed by JL, independently of
Tdh. The nature of the intervention precluded formal
masking of fieldworkers.
The allocation of the intervention to each district was
gradually communicated by the research team to the
implementing agencies and the list of surveyed facilities
was not communicated to reduce the likelihood that
more intensive support was provided to those facilities.
Sample size
The sample size was determined using the method de-
scribed by Hussey and Hughes [22], assuming a design
effect of 2 due to clustering within facilities and a be-
tween cluster coefficient of variation of 0.3. With a har-
monic mean of ten children seen at each of the ten
selected health facility of the eight districts per step (and
therefore 100 children per district and 800 children per
step), the trial would provide 90% power to detect an in-
crease in any of the primary outcome from 25 to 33% %.
With a harmonic mean of only four children seen per
facility at each step, the trial would have 98% power to
detect an increase from 25 to 40% [21].
Data collection
Data collection was conducted by two teams, each com-
prising two trained nurses. At each step, all ten selected
primary facilities in each of the eight districts, were vis-
ited once for data collection. Data were collected for all
consultations of children aged 2 months to 5 years old
occurring during the research team’s visit to the facility.
Each visit lasted 2 days or less if the required minimum
sample size of children observed per facility was
achieved. At each step, the newest intervention district
was visited last to maximise the chances that HCWs had
learnt how to use the new technology. Each visit was
Fig. 2 a Stepped-wedge design: planned roll-out of the IeDA intervention. b Stepped-wedge design: actual roll-out of the IeDA intervention.
Districts shaded in dark green had full implementation of the IeDA intervention. Districts shaded in light green had partial implementation of the
IeDA intervention (“contaminated” control districts)
Sarrassat et al. BMC Health Services Research          (2021) 21:354 Page 4 of 19
notified, by the data collection team, to the facility the
day before the visit.
One independent trained nurse observed the consult-
ation and recorded, using a structured and pre-tested
observation form programmed into a tablet, the HCW’s
clinical practices, illness classifications and prescriptions
given to the child. Observations were passive, and the
observer never intervened during the consultation. Val-
idation data were collected by the second independent
trained nurse, who conducted a repeat consultation with
the child, using the eCDSS. These validation data
were intended to provide a “gold standard” classifica-
tion for each child. When there were discrepancies
between the HCW and the validation nurse, the final
management of the child was agreed by discussion
between the two of them.
In addition, at each visit, a shortened version of the
WHO Service Availability and Readiness Assessment
(SARA) questionnaire [23] was completed to document
the availability of essential medicines and equipment re-
quired by IMCI guidelines.
The four nurses recruited for data collection had pre-
viously been trained in IMCI by the MoH. The two
nurses responsible for observation of consultations had
at least 5 years of experience working in a health centre.
The two validation nurses had at least 10 years of ex-
perience working in a health centre and were also IMCI
trainers. In addition, all underwent 2 weeks of training,
provided by the main investigators, on the study
methods and tools prior to the trial, and benefited from
two refresher trainings, provided by Tdh, on IMCI and
the eCDSS during the trial.
Outcomes
The evaluation focussed on the adherence to IMCI
charts designed for new consultations of children aged 2
months to 5 years old to assess, classify and treat danger
signs, cough/difficult breathing, diarrhoea, fever and nu-
tritional status.The evaluation did not consider IMCI
charts designed for children who return after an intial
consultation. We excluded charts related to HIV and ear
problems due to their very low prevalence during the
trial period (across all steps and according to the valid-
ation nurses, only 0.9% of children classified with HIV
infection, and 2.7% of children classified with ear prob-
lems). We also excluded the charts related to vitamin A
supplementation and vaccination as coverage was high
in Burkina Faso. Upon the advice of the trial’s scientific
advisory committee, for anaemia, only adherence to the
clinical assessment task was evaluated due to the diffi-
culty of assessing anaemia reliably when laboratory test-
ing was locally unavailable.
Primary and secondary outcomes are defined in the
Additional file 1. Briefly, the primary outcomes included:
1. overall adherence to clinical assessment tasks; 2. over-
all correct classification ignoring the severity of the clas-
sifications (upon the advice of the trial’s scientific
advisory committee); and 3. overall correct prescription
according to HCWs’ classifications. The secondary out-
comes included: 1. adherence to assessment of danger
signs; 2. correct identification of at least one danger sign;
3. overall correct classification accounting for the sever-
ity of the classifications; 4. overall correct prescription
according to validation nurses’ classifications; 5 & 6.
overall correct referral or hospitalisation according to
HCWs’ assessment and to validation nurses’ assessment;
and 7. overall correct treatment counselling.
Other reported outcomes are: sensitivity and speci-
ficity of the HCWs’ classifications; over-prescription
of antibiotics and antimalarials; overall availability
index of essential oral medicines and equipment
(Additional file 2).
Analyses
Analyses were performed using Stata version 14. Ana-
lysis included all new consultations of children aged 2
months to 5 years old and excluded children who return
after an intial consultation for a follow-up consultation.
Primary analyses included “contaminated” control dis-
tricts as control districts based on the intention-to-treat
(ITT) principle.
Secondary analyses excluded these districts for the
period when they were contaminated.
Descriptiive analyses were performed using individual-
level data and point estimates and confidence intervals
for all outcomes were computed accounting for the clus-
tering of observations within districts and facilities using
the svy family of commands in Stata.
Comparisons between trial arms and statistical tests to
investigate evidence of an intervention effect were per-
formed on cluster/step-level summaries as recom-
mended by Hayes and Moulton [24] for trials with fewer
than about 15 clusters per arm to account for the clus-
tered nature of the data. A “vertical” stepped wedge ana-
lysis was performed with permutation test using the
swpermute command in Stata [25]. This approach ana-
lyses each step as a parallel arm trial or, in other words,
computes, for each step, one cluster summary per dis-
trict and one effect estimate and then combines these
step-level effect estimates into a weighted average (with
the weights proportional to the harmonic mean of the
number of clusters in each arm and step). This ap-
proach, recommended by Thomson et al. [26], preserves
the randomisation and accounts for secular trends.
“Horizontal” comparisons, i.e. comparison within a clus-
ter over time (which are non-randomised), do not con-
tribute to the analysis. Applied to our design, across the
six steps and the eight clusters, 46 cluster/step
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summaries were computed (two cluster/step-level sum-
maries were excluded from the analysis due to data lost
in two districts at step 6 and 7 respectively) giving six ef-
fect estimates which were then combined into a
weighted average for each of our outcome.
The above approach was used for all primary and sec-
ondaty outomes with the exception of correct identifica-
tion of at least one danger sign and overall correct
referral/hospitalisation. Given the very small number of
children with danger signs or severe classifications war-
ranting referral/hospitalisation who contributed to these
two outcomes, Fisher’s exact test, performed on individ-
ual level data and ignoring clustering, was used to test
for an intervention effect.
Statistical tests to investigate evidence of a differ-
ence between trial arms were only performed on the
primary and secondary outcomes to reduce the prob-
lem of multiple testing. No formal adjustment was
made for multiple testing. Because our ten endpoints
are not all independent to each other, applying the
Bonferronni correction would be overly conservative
(as it assumes that all hypotheses being tested are in-
dependent of each other).
Results
After excluding 189 follow-up consultations, data were
recorded for 2724 new consultations of children aged 2
months to 5 years old: 686 consultations at baseline,
1343 consultations in control districts and 695 consulta-
tions in intervention districts (Fig. 3, Additional file 4).
About half of consultations at baseline and in the con-
trol and intervention districts (46%, 317/686, 49%, 658/
1343, and 48%, 335/695 respectively) were conducted in
districts where the concurrent PBF intervention was
implemented.
While the IMCI paper-form was used for 70% (479/
686) and 68% (918/1343) of the consultations at baseline
and in control clusters respectively, the eCDSS was used
in nearly all consultations (97%, 674/694) in intervention
clusters. The occasional use of the eCDSS at baseline
(1%, 8/686) or in the control districts (9%, 120/1343) re-
flects instances of early roll-out of the eCDSS prior to
training.
Gender and age distributions were similar at baseline
and by trial arm (Table 1). Based on validation nurses’
assessment, the most common classification given to
children was malaria (between 53 and 69% of children
across baseline and trial arms) (Table 2). Other common
classifications included: diarrhoea with no dehydration
(about 27%) and pneumonia (between 16 and 27%).
About 45% of children had one classification only and
between 33 and 48% had two or more classifications
(Table 3).
Adherence to clinical assessment
Across the six IMCI charts, the average percentage of
tasks completed by the HCWs was 48% at baseline, 54%
in the control districts and 79% in the intervention dis-
tricts with evidence for a difference between trial arms
(cluster-level mean difference = 30%; P-value = 0.002)
(Table 4). For all IMCI charts, HCWs in the intervention
districts completed more of the recommended tasks
compared to HCWs in the control districts (Table 5). In
particular, more of the recommended tasks were com-
pleted for assessing danger signs: 95% versus 34% in the
intervention and control districts respectively (cluster-
level mean difference = 71%; P-value = 0.002) (Table 4).
Identification of danger signs
The proportion of children correctly identified, by the
HCWs, with at least one danger sign was 67% (16/24) at
baseline and 56% (14/25) in the control districts. It ap-
peared to be somewhat higher (75%, 12/16) in the inter-
vention districts but the small number of children with
danger signs preclude firm conclusion (cluster-level
mean difference = 19%; P-value = 0.322) (Table 4).
Classification
Ignoring the severity of the classifications, the proportion
of children for whom the validation nurses and the HCWs
recorded the same classifications was 75% (457/609) at
baseline, 73% (767/1049) in the control districts and 79%
(450/572) in the intervention districts with evidence for a
difference between trial arms (cluster-level mean differ-
ence = 10%; P-value = 0.004) (Table 4). Accounting for the
severity of the classifications slightly lowered the propor-
tions of correct classifications (cluster-level mean differ-
ence = 9%; P-value = 0.038) (Table 4).
By IMCI chart, HCWs in the intervention districts
correctly classified children having diarrhoea with no de-
hydration, dysentery and acute malnutrition (severe or
moderate) more often than those in the control districts
(Table 6). Although based on a small number of chil-
dren, HCWs in intervention districts also appeared to
correctly classify children with severe malaria or severe
febrile illness more often than those in control districts.
HCWs in the intervention districts were also less likely
to wrongly diagnose pneumonia as being present when
it was not: 7% (38/521) versus 19% (209/1113) (Table 7).
For other conditions, false positive diagnoses were rare
(< 5%) in both arms.
Prescription
Overall, the proportion of children who received all the
recommended prescriptions in accordance with the
HCWs’ classifications was 76% (465/614) at baseline,
78% (836/1074) in the control districts and 77% (437/
567) in the intervention districts with no evidence for a
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Fig. 3 Trial flow diagram (number of consultations of children aged 2 to 60 months). * Eight districts randomised but only 4 actually received the
IeDA intervention
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difference between trial arms (cluster-level mean dif-
ference = − 1%; P-value = 0.788) (Table 4). According
to the validation nurses’ classifications, these propor-
tions were 65% (398/610) at baseline, 66% (693/1049)
in the control districts and 69% (392/572) in the
intervention districts (cluster-level mean difference =
7%; P-value = 0.226).
By IMCI chart, correct prescriptions for dysentery
were much more common in the intervention districts
than in the control districts, as were correct prescrip-
tions for acute malnutrition (severe without complica-
tions or moderate) and severe malaria or severe febrile
illness, although still infrequent (Tables 8 and 9).
Correct prescriptions for diarrhoea with no dehydration
were also higher in the intervention districts compared
to the control districts (Table 9).
Over-prescription
According to the HCWs’ classifications, the proportion
of children who were not in need of an antibiotic but
who were actually prescribed one was 11% (77/681) at
baseline, 14% (187/1341) in the control districts and 8%
(56/694) in the intervention districts (Table 10). Accord-
ing to validation nurses’ classifications, these proportions
were 18% (123/668) at baseline, 23% (289/1252) in the
control districts and 10% (69/676) in the intervention
Table 1 Child’s gender and age at baseline and by trial arm
Baseline (N = 686) Control arm (N = 1343) Intervention arm (N = 695)
% % %
Gender Females 45.3 44.4 45.9
Males 54.7 55.6 54.1
Total 100.0 100.0 100.0
Age (months) 2–11 31.8 29.0 31.7
12–23 28.6 30.9 27.8
24–35 18.4 17.9 18.9
36–47 11.4 12.2 12.4
48–60 9.9 10.0 9.4
Total 100.0 100.0 100.0
Table 2 Validation nurses’ classifications at baseline and by trial arm
Baseline (N = 686) Control arm (N = 1343) Intervention arm (N = 695)
Classification % % %
Severe pneumonia or very severe disease 2.2 0.7 0.6
Pneumonia 27.3 16.2 24.3
Severe dehydration 0.7 0.1 0.0
Dehydration 0.7 0.2 0.4
Diarrhoea with no dehydration 25.7 25.5 27.2
Severe persistent diarrhoea 0.0 0.0 0.0
Persistent diarrhoea 0.0 0.0 0.0
Dysentery 1.8 2.0 1.7
Severe malaria or severe febrile illness 3.4 1.8 2.5
Malaria 69.4 54.7 52.7
Severe and complicated measles 0.0 0.0 0.0
Measles with eyes or mouth complications 0.0 0.0 0.0
Measles 0.0 0.0 0.0
Severe anaemia 0.4 0.2 0.1
Anaemia 12.5 6.6 4.5
Severe acute malnutrition 4.6 4.9 4.0
Moderate acute malnutrition 10.8 11.4 16.2
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districts (Table 11). With respect to antimalarials, a
Rapid Diagnostic Test (RDT) was performed for about
90% of febrile children in both arms (Table 5) and over-
prescription was low and similar at baseline and between
trial arms: around 2 to 4%.
Referral/ hospitalisation
Overall, the proportion of children in need of referral or
hospitalisation according to the HCWs’ assessment who
were actually referred or hospitalised by the HCWs was
60% (21/35) at baseline, 52% (22/42) in the control
Table 3 Number of classifications according to validation nurses at baseline and by trial arm
Number of
classifications
Baseline (N = 686) Control arm (N = 1343) Intervention arm (N = 695)
% % %
0 10.5 21.3 17.3
1 41.3 45.5 44.6
2 32.7 24.7 28.4
3 11.8 6.9 8.5
4 3.2 1.5 1.2
5 0.6 0.2 0.1
Total 100.0 100.0 100.0
Table 4 Primary and secondary outcomes
Adherence to clinical assessment Baseline Control arm Intervention arm Cluster-level mean
difference between arms
P-value*
N % 95%CI N % 95%CI N % 95%CI
Overall adherence (13 to 33 tasks) 686 48.0 44.3 51.6 1343 54.3 50.6 58.0 695 79.3 72.7 85.9 29.9 0.002
Adherence to danger signs’
assessment (3 tasks)
686 18.4 12.0 24.9 1343 34.2 25.5 42.9 695 95.2 90.0 99.9 71.2 0.002
Identification of at least one
danger sign (proportion of children
correctly identified with at least one
danger sign)
Baseline Control arm Intervention arm Individual-level difference
between arms
P-value**
Na % 95%CI Na % 95%CI Na % 95%CI
24 66.7 47.2 81.7 25 56.0 30.8 78.4 16 75.0 50.5 89.8 19.0 0.322
Overall correct classification
(proportion of children correctly
classified with x given classifications)
Baseline Control arm Intervention arm Cluster-level mean
difference between arms
P-value*
Nb % 95%CI Nb % 95%CI Nb % 95%CI
Accounting for the severity of
classifications
609 70.6 63.7 76.7 1049 69.8 66.0 73.4 572 74.7 66.9 81.1 9.1 0.038
Ignoring the severity of the
classifications
609 75.0 68.0 81.0 1049 73.1 68.8 77.0 572 78.7 72.9 83.5 10.1 0.004
Overall correct prescription
(proportion of children who received
at least all the recommended
prescriptions)
Baseline Control arm Intervention arm Cluster-level mean difference
between arms
P-value*
Nc % 95%CI Nc % 95%CI Nc % 95%CI
According to the HCWs’ classifications 614 75.7 68.0 82.1 1074 77.8 72.5 82.4 567 77.1 71.6 81.8 −1.1 0.788
According to the validation nurses’
classifications
610 65.3 59.8 70.4 1049 66.1 60.7 71.0 572 68.5 58.8 76.9 6.7 0.226
Overall correct referral/hospitalisation
(proportion of children in need of referral/
hospitalisation who were actually referred/
hospitalised)
Baseline Control arm Intervention arm Individual-level difference
between arms
P-value**
Nd % 95%CI Nd % 95%CI Nd % 95%CI
According to the HCWs’ classifications 35 60.0 47.7 71.1 42 52.4 23.7 79.6 41 61.0 21.5 89.9 8.6 0.509
According to the validation nurses’
classifications
29 55.2 36.0 72.9 32 53.1 36.5 69.1 22 68.2 47.8 83.4 15.1 0.398
Overall correct treatment counselling
(proportion of caretakers who received
information on home-based prescription)
Baseline Control arm Intervention arm Cluster-level mean difference
between arms
P-value*
Ne % 95%CI Ne % 95%CI Ne % 95%CI
612 77.3 67.5 84.8 1143 91.5 88.8 93.6 576 87.9 77.9 93.7 −4.1 0.355
* t test on cluster-level summaries & accounting for the stepped wedge design; ** Fisher’s exact test on individual-level data & ignoring clustering
aNumber of children identified, by the validation nurses, with a given danger sign
b Number of children classified, by the validation nurses, with x given classification
cNumber of children classified, by the HCWs or by the validation nurses, with x given classification
dNumber of children identified, by the HCWs or the validation nurses, with at least one danger sign or a classification requiring referral/hospitalisation
e Number of children who were prescribed, by the HCWs, x given treatment (regardless of the classification)
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Table 5 Adherence to clinical assessment by IMCI chart
IMCI chart Task: Questions to address to the mother
or examinations to perform
Baseline Control arm Intervention arm
N % 95%CI N % 95%CI N % 95%CI
Danger signs b Ask if the child is able to drink/breastfeed 686 15.9 9.2 26.1 1343 28.7 20.4 38.8 695 94.5 75.1 99.0
Ask if the child vomits everything 686 15.7 8.6 27.0 1342 40.8 33.0 49.0 695 95.8 81.2 99.2
Ask about recent convulsions a 686 23.6 15.0 35.1 1342 33.1 23.3 44.6 695 95.3 90.3 97.7
Adherence index (3 tasks) 686 18.4 12.0 24.9 1343 34.2 25.5 42.9 695 95.2 90.0 99.9
Cough/difficult breathing Ask about cough a 686 94.8 90.4 97.2 1342 94.3 87.2 97.6 695 99.4 97.4 99.9
Ask about difficult breathing a 686 2.8 1.6 4.8 1295 7.9 3.1 18.6 605 11.4 4.0 28.5
Ask for duration (if cough/difficult breathing) 188 93.1 85.4 96.9 450 82.2 74.4 88.1 324 96.9 87.5 99.3
Count number of breaths per minute
(if cough/difficult breathing)
317 54.9 40.6 68.4 554 44.8 34.0 56.1 340 88.5 79.2 94.0
Look for chest indrawing
(if cough/difficult breathing)
318 47.8 37.5 58.2 554 41.2 28.9 54.7 340 82.4 75.0 87.9
Listen for stridor or “wheeze” breathing
(if cough/difficult breathing)
318 27.0 17.9 38.7 554 17.2 10.8 26.1 339 51.6 18.8 83.1
Adherence index (2 to 6 tasks) 686 48.3 44.4 52.2 1342 50.0 45.8 54.3 695 67.8 55.0 80.7
Diarrhoea c Ask about diarrhoea a 686 94.8 87.4 97.9 1343 92.3 85.1 96.2 695 98.7 94.8 99.7
Ask for duration (if diarrhoea) 152 92.1 86.2 95.6 340 87.1 80.0 91.9 178 96.6 90.5 98.9
Ask for blood in the stool (if diarrhoea) a 151 53.0 45.3 60.5 346 58.4 45.3 70.4 178 89.9 81.3 94.8
Offer water to the child (if diarrhoea) 151 9.9 3.1 27.5 347 6.6 3.6 11.8 178 41.6 21.7 64.6
Pinch the skin of the abdomen (if diarrhoea) 98 46.9 35.0 59.3 285 47.0 26.1 69.0 172 76.7 65.7 85.0
Adherence index (1 to 5 tasks) 686 86.2 81.3 91.2 1343 82.1 74.9 89.2 695 93.8 91.6 96.1
Fever or history of fever d Ask about current fever a 686 88.2 72.7 95.4 1343 96.9 92.1 98.8 694 100.0 – –
Ask about history of fever a 686 23.5 14.0 36.6 1319 75.1 51.2 89.7 654 72.9 42.8 90.6
Ask for duration (if fever) 543 91.7 87.0 94.8 1027 88.4 84.5 91.4 575 96.7 95.0 97.8
Ask if the child had fever every day
(if fever > 7 days)
8 25.0 2.8 79.5 10 40.0 13.6 73.9 4 75.0 17.4 97.7
Ask if urine are dark or not abundant
(if fever)
544 10.9 6.8 16.9 1081 19.8 13.9 27.5 581 81.2 67.8 89.9
Ask about abnormal bleeding (if fever) 544 6.3 3.0 12.4 1081 14.7 7.5 26.8 581 75.7 59.0 87.1
Ask about history of measles in the past
3 months (if fever)
544 10.9 6.4 17.8 1081 17.7 13.2 23.2 581 65.8 29.7 89.7
Take the temperature (if fever) 544 99.8 98.4 99.9 1082 99.1 98.5 99.4 586 99.7 98.9 99.9
Perform a RDT (if fever) 544 74.3 53.8 87.7 1082 86.7 79.5 91.6 584 93.7 88.6 96.6
Look for neck stiffness (if fever) 544 16.2 7.6 31.3 1081 23.0 15.2 33.3 582 47.6 37.8 57.6
Take the pulse (if fever) 544 2.4 0.5 9.9 1075 8.2 2.7 22.3 582 1.6 0.4 5.6
Look for cold hands or feet (if fever) 544 1.3 0.4 4.5 1078 1.2 0.5 2.7 578 33.7 11.0 67.7
Look for jaundice or redness in the
eyes (if fever)
544 82.5 70.8 90.2 1081 83.0 73.3 89.6 584 94.0 86.9 97.4
Look for general rash (if fever) 544 14.9 7.4 27.6 1082 14.1 9.3 20.6 583 34.3 21.0 50.6
Adherence index (2 to 14 tasks) 686 40.3 38.1 42.5 1343 52.5 47.8 57.2 694 71.5 65.6 77.4
Anaemia Look for palmar pallor 686 59.9 44.2 73.8 1341 51.5 42.6 60.4 692 92.2 78.4 97.5
Nutritional status e Measure height 686 88.3 61.8 97.3 1343 90.4 79.1 95.9 695 99.6 98.9 99.8
Weigh the child 686 98.5 94.3 99.6 1343 98.4 93.7 99.6 695 99.1 97.5 99.7
Measure MUAC 686 84.3 70.4 92.3 1342 86.1 82.2 89.2 692 88.4 83.5 92.1
Look for feet oedema 686 23.5 14.3 36.1 1342 35.1 22.8 49.8 692 86.6 55.0 97.1
Offer RUTF (if age > 5months & MUAC
< 115 mm & no danger sign or severe
classification)
17 0.0 – – 34 8.8 1.9 32.8 16 43.8 20.3 70.4
Adherence index (4 to 5 tasks) 686 73.2 64.5 81.9 1343 77.1 71.6 82.5 695 93.2 87.3 99.1
a Or reported by the caretakers spontaneously when the consultation started or when asked the reason for consulting; b Tasks recommended by the IMCI guidelines
but not observable during consultations: Observe if the child convulses, observe if the child is lethargic/unconscious; c Tasks recommended by the IMCI guidelines but
not observable during consultations: Observe if the child is lethargic/unconscious (if diarrhoea), observe if the child is restless/irritated (if diarrhoea), look for sunken
eyes (if diarrhoea); d Tasks recommended by the IMCI guidelines but not observable during consultations: Look for running nose (if fever); e Tasks recommended by the
IMCI guidelines but not observable during consultations: Look for severe and visible weight loss
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districts and 61% (25/41) in the intervention districts
with no evidence for a difference between trial arms
(individual-level mean difference = 9%; P-value = 0.509)
(Table 4). According to the validation nurses’ assess-
ment, these proportions were 55% (16/29) at baseline,
53% (17/32) in the control districts and 68% (15/22) in
the intervention districts (individual-level mean differ-
ence = 15%; P-value = 0.398).
Treatment counselling
The proportion of caretakers to whom the HCWs men-
tioned both the number of doses a day and the number
Table 6 Sensitivity of the HCW’s classification: Proportion of children correctly classified in a given classification
Baseline Control arm Intervention arm
Classification Na % 95%CI Na % 95%CI Na % 95%CI
Severe pneumonia or very severe disease 14 14.3 2.5 51.7 10 20.0 1.3 82.6 4 25.0 – –
Pneumonia 185 75.7 66.6 82.9 218 71.6 65.6 76.9 169 76.3 46.8 92.2
Pneumonia ignoring severity 199 75.9 67.0 83.0 228 73.3 65.8 79.5 173 78.6 50.5 93.0
Severe dehydration 5 60.0 20.1 90.0 1 0.0 – – 0 – – –
Dehydration 5 80.0 17.1 98.7 2 50.0 0.6 99.4 3 66.7 1.1 99.7
Diarrhoea with no dehydration 175 58.3 44.5 70.9 343 64.7 51.9 75.7 189 74.6 62.9 83.6
Severe persistent diarrhoea 0 – – – 0 – – – 0 – – –
Persistent diarrhoea 0 – – – 0 – – – 0 – – –
Diarrhoea ignoring severity 185 61.1 48.1 72.7 346 65.9 52.6 77.1 192 76.6 64.8 85.3
Dysentery 12 41.7 22.9 63.2 27 44.4 29.3 60.6 12 83.3 17.8 99.1
Severe malaria or severe febrile illness 23 60.9 37.7 80.0 24 62.5 36.1 83.1 17 82.4 53.2 95.0
Malaria 475 93.9 90.9 96.0 734 92.0 87.6 94.9 366 91.0 87.7 93.4
Malaria ignoring severity 498 95.0 91.9 96.9 758 93.1 90.0 95.3 383 93.0 87.5 96.1
Severe acute malnutrition 22 81.8 50.0 95.3 45 57.8 37.6 75.6 23 91.3 67.6 98.1
Moderate acute malnutrition 56 46.4 29.9 63.8 120 41.7 31.6 52.5 95 62.1 52.2 71.1
Malnutrition ignoring severity 78 68.0 52.8 80.0 165 55.2 45.5 64.4 118 75.4 63.1 84.6
a Number of children classified, by the validation nurses, with a given classification
Table 7 Specificity of the HCW’s classification: Proportion of children correctly not classified in a given classification
Baseline Control arm Intervention arm
Classification Na % 95%CI Na % 95%CI Na % 95%CI
Severe pneumonia or very severe disease 640 99.8 98.6 99.9 1331 99.5 98.4 99.8 690 98.8 96.3 99.6
Pneumonia 469 82.5 72.0 89.6 1123 81.2 72.5 87.6 525 93.1 78.4 98.1
Pneumonia ignoring severity 455 83.7 73.4 90.6 1113 81.2 72.9 87.4 521 92.7 76.4 98.0
Severe dehydration 675 100.0 – – 1342 99.9 99.4 99.9 695 100.0 – –
Dehydration 681 99.7 98.3 99.9 1341 99.6 98.5 99.9 692 99.3 98.6 99.6
Diarrhoea with no dehydration 505 97.0 94.9 98.3 1000 94.7 89.0 97.5 506 98.8 97.4 99.5
Severe persistent diarrhoea 680 99.9 98.1 99.9 1343 100.0 – – 695 100.0 – –
Persistent diarrhoea 680 99.9 98.1 99.9 1343 100.0 – – 695 99.9 99.1 99.9
Diarrhoea ignoring severity 495 97.0 94.8 98.2 997 94.5 88.8 97.4 503 98.4 95.6 99.4
Dysentery 667 97.5 93.0 99.0 1316 97.5 95.0 98.8 683 99.6 98.9 99.8
Severe malaria or severe febrile illness 660 98.8 97.7 99.4 1319 99.2 96.1 99.8 678 98.5 96.1 99.5
Malaria 208 90.9 83.4 95.2 609 95.2 90.7 97.6 329 95.7 91.9 97.8
Malaria ignoring severity 185 92.4 85.6 96.2 585 95.9 92.3 97.9 312 95.2 91.8 97.2
Severe acute malnutrition 563 97.9 95.4 99.0 1100 98.9 98.4 99.3 589 98.5 96.7 99.3
Moderate acute malnutrition 529 93.6 89.7 96.0 1025 96.8 94.0 98.3 517 96.5 94.3 97.9
Malnutrition ignoring severity 507 92.7 89.2 95.2 980 96.9 94.0 98.5 494 96.4 94.1 97.8
a Number of children not classified, by the validation nurses, with a given classification
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of days for all the relevant oral medicines prescribed for
treating the child at home was 77% (473/612) at base-
line, 92% (1046/1143) in the control districts and 88%
(506/576) in the intervention districts with no evidence
for a difference between trial arms (cluster-level mean
difference = − 4.1%; P-value = 0.355) (Table 4). For all
oral medicines, both the number of doses per day and
the number of days were mentioned by the HCWs to a
high proportion of caretakers at baseline and in both
trial arms (Table 12).
Availability of essential oral medicines and equipment
The average proportion of essential oral medicines that
were observed to be available at the health facilities was
high: 98% at baseline, 94% in the control districts and
89% in the intervention districts (Table 13). However,
deworming treatments, amoxicillin, ORS and multivita-
mins were less frequently available in the intervention
districts compared to the control districts.
With respect to essential equipment, availability at the
health facilities was high: 87% at baseline, 87% in the
control districts and 91% in the intervention districts.
Better availability of electricity and equipment to admin-
ister ORS was observed in the intervention districts
compared to the control districts.
Explanatory analyses
Comparison of HCWs’ performance with and without use of
IMCI paper-forms in the control districts
In order to assess whether the frequent use of IMCI
paper-based form in the control districts had an effect
on HCWs performance, primary and secondary out-
comes in the control districts were compared between
HCWs who were observed to use an IMCI paper-form
and those who did not.
Surprisingly, HCWs who did not use an IMCI paper-
form in the control districts seem to have better assessed
danger signs than those who used a form: on average
they performed 45% versus 22% of the recommended
tasks respectively (Additional file 5). For all other out-
comes, HCWs’ performance was similar between the
two groups.
Agreement between HCWs and validation nurses’ clinical
assessment
The square root of the mean square errors (RMSE) for
the differences in child’s weight, height and temperature
measurements between HCWs and validation nurses in-
dicate differences of a small magnitude (< 1 kg, < 3 cm
or < 1 °C) at baseline and in the trial arms (Add-
itional file 6a). Higher RMSE were observed between
Table 8 Correct prescription according to the HCWs’ classifications: Proportion of children who received at least all the
recommended prescriptions
Baseline Control arm Intervention arm
Classification Nb % 95%CI Nb % 95%CI Nb % 95%CI
Severe pneumonia or very severe disease 3 33.3 2.2 91.7 9 44.4 9.7 85.7 9 55.6 25.5 82.0
Pneumonia 222 93.2 89.7 95.6 367 94.8 86.7 98.1 165 95.2 92.8 96.8
All classifications related to pneumonia 225 92.4 88.1 95.3 376 93.6 86.2 97.2 174 93.1 88.8 95.8
Severe dehydration with another severe classification 3 33.3 2.2 91.7 1 0.0 – – 0 – – –
Severe dehydration without another severe classification 0 – – – 0 – – – 0 – – –
Dehydration with other severe classification 3 66.7 8.3 97.8 2 50.0 0.6 99.4 2 100.0 – –
Dehydration without other severe classification 3 100.0 – – 5 80.0 7.1 99.5 5 100.0 – –
Diarrhoea with no dehydration 117 70.1 52.7 83.1 275 84.0 79.4 87.7 147 88.4 73.3 95.5
Severe persistent diarrhoea 1 100.0 – – 0 – – – 0 – – –
Persistent diarrhoea 1 0.0 – – 0 – – – 1 0.0 – –
All classifications related to diarrhoea 128 69.5 53.3 82.0 283 83.4 79.3 86.8 155 88.4 72.8 95.6
Dysentery 22 0.0 – – 45 11.1 2.3 39.4 13 69.2 34.7 90.5
Severe malaria or severe febrile illness 22 9.1 1.6 38.6 26 7.7 1.3 34.6 24 33.3 7.9 74.5
Malaria 465 98.9 97.4 99.6 704 98.9 97.3 99.5 347 98.3 96.1 99.2
All classifications related to malaria 487 94.9 91.9 96.8 730 95.6 93.1 97.2 371 94.1 84.9 97.8
Severe acute malnutrition with complicationsa 3 0.0 – – 5 40.0 7.2 85.1 0 – – –
Severe acute malnutrition without complications 25 32.0 17.3 51.5 35 17.1 5.0 45.0 30 40.0 30.7 50.1
Moderate acute malnutrition 64 12.5 7.0 21.2 84 1.2 0.1 11.1 82 8.5 5.1 14.0
All classifications related to malnutrition 95 16.8 10.3 26.3 124 7.3 4.2 12.3 112 17.0 10.1 27.0
a Any danger sign or other severe classification
b Number of children classified, by the HCWs, with a given classification
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HCWs and validation nurses’ measurements of mid-
upper arm circumference (MUAC) (around 5mm) and
respiratory count (around 9 counts). All differences were
fairly balanced between trial arms.
With respect to RDT results and caretakers’ answers
about children’s key symptoms, actual agreement
between HCWs and validation nurses were high (> 90%)
at baseline and in the trial arms (Additional file 6b). The
Kappa coefficients indicate that 90% or more of RDT re-
sults were in agreement beyond that expected by chance.
The Kappa coefficients for caretakers’ answers range
from 0.60 to 0.88.
Table 9 Correct prescription according to the validation nurses’ classifications: Proportion of children who received at least all the
recommended prescriptions
Baseline Control arm Intervention arm
Classification Nb % 95%CI Nb % 95%CI Nb % 95%CI
Severe pneumonia or very severe disease 15 6.7 0.7 43.6 10 0.0 – – 4 0.0 – –
Pneumonia 187 81.8 74.1 87.6 218 78.9 70.8 85.2 169 81.1 61.5 92.0
All classifications related to pneumonia 202 76.2 69.1 82.2 228 75.4 65.3 83.4 173 79.2 55.2 92.1
Severe dehydration with another severe classification 5 20.0 2.7 69.1 1 0.0 – – 0 – – –
Severe dehydration without another severe classification 0 – – – 0 – – – 0 – – –
Dehydration with other severe classification 1 100.0 – – 2 50.0 – – 0 – – –
Dehydration without other severe classification 4 50.0 4.3 95.7 0 – – – 3 66.7 – –
Diarrhoea with no dehydration 176 50.0 40.5 59.5 343 65.6 57.5 72.9 189 76.7 52.9 90.6
Severe persistent diarrhoea 0 – – – 0 – – – 0 – – –
Persistent diarrhoea 0 – – – 0 – – – 0 – – –
All classifications related to diarrhoea 186 49.5 39.8 59.2 346 65.3 57.5 72.4 192 76.6 52.1 90.8
Dysentery 12 8.3 0.7 54.0 27 11.1 2.1 42.4 12 75.0 29.2 95.6
Severe malaria or severe febrile illness 23 8.7 1.4 38.7 24 0.0 – – 17 29.4 4.5 78.7
Malaria 476 94.5 91.7 96.4 734 94.1 90.3 96.5 366 95.4 92.1 97.3
All classifications related to malaria 499 90.6 87.1 93.2 758 91.2 87.0 94.1 383 92.4 82.4 97.0
Severe acute malnutrition with complicationsa 3 0.0 – – 3 33.3 0.1 99.9 0 – – –
Severe acute malnutrition without complications 19 15.8 5.5 37.8 42 14.3 4.1 39.6 23 43.5 33.0 54.6
Moderate acute malnutrition 57 8.8 4.6 16.2 121 2.5 0.5 11.2 95 8.4 5.4 12.9
All classifications related to malnutrition 79 10.1 5.3 18.6 166 6.0 3.9 9.2 118 15.3 11.1 20.6
a Any danger sign or other severe classification
b Number of children classified, by the validation nurses, with a given classification
Table 10 Over-prescription according to the HCWs’ classifications: Proportion of children who were not in need of a given
medicine but who were actually prescribed it
Baseline (N = 686) Control arm (N = 1343) Intervention arm (N = 695)
Medicines % 95%CI % 95%CI % 95%CI
Ampicillin injectable 0.0 – – 0.1 – – 0.3 0.0 1.8
Gentamycin injectable 0.0 – – 0.0 – – 0.1 – –
Cotrimoxazole 6.1 4.0 9.3 6.7 4.5 9.8 1.9 0.8 4.3
Amoxicillin 4.0 2.2 7.1 5.8 3.3 10.0 5.0 3.3 7.6
Ciprofloxacin 0.3 – – 0.0 – – 0.3 – –
Metronidazole 0.9 0.2 3.8 2.0 1.4 2.8 0.6 0.1 2.2
All antibiotics 11.3 8.3 15.3 13.9 9.2 20.5 8.1 5.2 12.4
Artesunate or Artemether injectable 0.4 0.1 1.5 0.1 – – 0.1 – –
Quinine injectable 0.0 – – 0.0 – – 0.0 – –
Artemisinin-based Combinnation Therapy (ACT) 1.3 0.5 3.8 1.7 0.7 4.0 2.6 1.0 6.8
All antimalarials 1.8 0.8 3.8 1.8 0.8 4.0 2.7 1.0 7.2
ACT Artesunate + Amodiaquine or Artemether/ Lumefantrine
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Secondary analyses
Excluding “contaminated” control districts for the period
when they were contaminated removed a total of 173
consultations from the analysis and made little or no
difference to the results (Additional file 7).
Discussion
The IeDA intervention improved substantially HCW’s
adherence to IMCI’s clinical assessment tasks (30% point
increase on average across the intervention districts
compared to the control districts), including the assess-
ment of danger signs, which led to some overall increase
in the proportion of children being correctly classified
(around 10% point increase on average across the inter-
vention districts compared to the control districts) but
to no improvement in overall proportion of children re-
ceiving correct prescriptions. The intervention, however,
appeared to have reduced over-prescription of anti-
biotics by 6 to 13% points.
Achieving correct classification depends, at least in
part, on the clinical skills of the HCWs, which may be
more difficult to improve than task adherence itself and
may have limited the effect of the intervention on cor-
rect classification. Recent more advanced clinical charts,
also built on electronic tools, such as electronic point-
of-care tests (ePOCT) integrating malaria RDT, haemo-
globin, pulse oximetry in all febrile patients and other
tests (e.g. glucometer, C-reactive protein) in subgroups
of them, have led to major improvements in febrile
disease classification and a considerable reduction of
antibiotic prescription [27].
In addition, using the eIMCI in Burkina Faso, im-
provements in classifications and prescriptions tended to
be observed for less common conditions, such as
dysentery and malnutrition, for which HCWs in the
control districts performed relatively poorly. The data
were also consistent with an improvement in danger
sign identification, correct referrals/hospitalisations and
Table 11 Over-prescription according to the validation nurses’ classifications: Proportion of children who were not in need of a
given medicine but who were actually prescribed it
Baseline (N = 686) Control arm (N = 1343) Intervention arm (N = 695)
Medicines % 95%CI % 95%CI % 95%CI
Ampicillin injectable 0.6 0.2 1.4 0.3 0.1 1.5 1.0 0.3 2.9
Gentamycin injectable 0.0 – – 0.3 0.1 1.6 0.9 0.3 2.2
Cotrimoxazole 10.4 6.0 17.3 8.6 5.4 13.5 1.3 0.4 3.7
Amoxicillin 5.3 3.1 8.9 10.7 5.7 19.2 6.5 3.2 12.5
Ciprofloxacin 0.2 – 1.5 0.2 – 0.7 0.3 0.1 0.6
Metronidazole 1.9 0.7 4.8 3.0 2.0 4.4 1.0 0.3 2.9
All antibiotics 18.4 11.8 27.5 23.1 16.3 31.7 10.2 4.7 20.7
Artesunate or Artemether injectable 0.7 0.3 2.0 0.6 0.1 4.1 0.7 0.3 1.7
Quinine injectable 0.4 0.1 1.5 0.2 – 1.4 0.7 0.3 1.7
Artemisinin-based Combinnation Therapy (ACT) 2.8 2.0 3.8 2.1 0.8 5.6 1.6 0.5 4.5
All antimalarials 3.9 2.6 6.0 2.8 1.2 6.3 3.0 1.2 7.4
ACT Artesunate + Amodiaquine or Artemether/ Lumefantrine
Table 12 Correct treatment counselling: Proportion of caretakers to whom the HCWs mentioned both the number of doses a day
and the number of days for home-based treatment
Treatment Baseline Control arm Intervention arm
Na % 95%CI Na % 95%CI Na % 95%CI
Oral antibiotics for pneumonia b 290 81.7 70.3 89.4 538 93.9 90.9 95.9 228 91.7 88.8 93.8
Artemisinin-based Combinnation Therapy (ACT) c 470 93.6 89.1 96.3 721 96.4 94.1 97.8 360 96.7 94.5 98.0
ORS 99 46.5 25.1 69.2 264 86.7 77.4 92.6 148 84.5 59.6 95.2
Zinc 99 83.8 74.9 90.0 268 94.0 91.7 95.7 153 87.6 63.9 96.6
Oral anti-infectious for dysentery d 19 57.9 26.5 84.0 54 83.3 69.5 91.7 18 94.4 70.0 99.2
Deworming treatments e 73 80.8 59.4 92.4 111 94.6 77.2 98.9 68 89.7 73.6 96.5
Iron/ folic acid 42 47.6 19.5 77.3 40 92.5 69.0 98.6 72 83.3 58.8 94.6
Plumpy nut or equivalent 28 32.1 17.6 51.3 16 75.0 41.0 92.8 27 63.0 55.8 69.6
aNumber of children who were prescribed, by the HCWs, a given treatment (regardless of the classification)
b Amoxicillin, Cotrimoxazole; c Artesunate + Amodiaquine, Artemether/ Lumefantrine; d Ciprofloxacin, Metronidazole; e Albendazole, Mebendazole
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management of severe malaria or severe febrile illness,
although small numbers of such children preclude firm
conclusions. For other, more common, conditions (e.g.
malaria or pneumonia), HCWs in the control districts
performed relatively well in classifying and prescribing
the correct medicines, thus limiting the scope to detect
an overall impact.
There were some notable differences between findings
at baseline and in the control arm with respect to preva-
lence of pneumonia (27 and 16% respectively), malaria
(69 and 55% respectively) and anaemia (13 and 7% re-
spectively). At baseline and in the control arm, 33 and
18% of observations respectively occurred from January
to March, during the peak of the pneumonia season.
Observations during the malaria season (July to Novem-
ber) were less frequent at baseline (49%) compared to
the control arm (61%). However, the higher prevalence
at baseline is consistent with the higher proportion of
positive RDT: 82% of RDTs were positive at baseline
compared to 66% during the control steps. These results
may reflect a more intense malaria season during the
baseline steps. This could also explain the difference in
anaemia prevalence, which is associated with malaria.
Our findings are broadly consistent with the limited
evidence available on the effectiveness of eCDSS for im-
proving adherence to IMCI (eIMCI). In 18 primary facil-
ities in four districts of Tanzania, only 21% of children
had all ten critical IMCI tasks assessed under paper-
Table 13 Availability of essential oral medicines and equipment
Baseline (N = 158) Control arm (N = 292) Intervention arm (N = 168)
N % N % N %
Oral medicine (availability observed with at least one unexpired)
Albendazole 158 94.3 290 93.5 166 79.5
Amoxicillin 158 97.5 291 89.7 166 73.5
Artesunate + Amodiaquine or Artemether/ Lumefantrine (ACT) 158 99.4 291 99.3 166 97.6
Ciprofloxacin 158 99.4 291 97.3 166 94.6
Cotrimoxazole 158 99.4 291 99.3 166 98.2
Iron and folic acid 157 98.7 291 98.6 165 94.6
Mebendazole 158 98.1 291 97.6 166 89.2
Metronidazole 158 100.0 290 99.7 166 97.6
Multivitamins 158 95.6 290 75.9 166 68.1
Oral Rehydration Salt (ORS) 158 94.3 291 93.1 166 85.5
Ready to use therapeutic food (RUTF) 158 96.2 289 92.0 166 91.0
Zinc 158 95.6 288 93.1 165 87.3
Vitamin A 158 100.0 290 98.6 164 97.0
Availability index of essential oral medicines (13 items) 158 97.6 291 94.4 166 88.7
Equipment (availability observed or reported)
Source of electricity 158 91.1 292 98.6 168 100.0
Electricity without any power cut in the last 7 days 155 41.9 198 33.3 254 66.7
Baby weighing scale (graduation 100 g) 157 100.0 291 99.3 168 100.0
Children weighing scale (graduation 250 g) 157 100.0 291 99.3 168 100.0
Measuring rod 157 100.0 291 99.3 168 100.0
Mid-upper arm circumference tape 157 100.0 290 99.7 168 100.0
Thermometer 157 100.0 256 99.6 166 99.4
Rapid Diagnostic Test 157 89.8 291 94.9 167 98.2
Source of clean water 158 91.8 292 96.2 163 97.0
Spoons, cups and jugs to mix and administer ORS 158 21.5 289 32.9 168 85.1
Kit for intravenous injection 157 94.3 292 64.7 166 31.3
Single-use syringes with disposable needles 157 100.0 292 99.0 167 99.4
Refrigerator 152 99.3 287 99.3 168 99.4
Availability index of essential equipment (13 items) 158 86.9 292 87.1 161 90.6
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based IMCI compared to 71% under eIMCI (p < 0.001)
[14]. In two basic health centres in the Kabul province
of Afghanistan, only 24% of children underwent a phys-
ical examination in line with IMCI at baseline compared
to 84% after 1 year of implementation (p < 0.05) [17].
Comparison of HCWs classifications with classifications
given by an independent nurse in Tanzania showed that
the electronic protocol improved overall correct classifi-
cation: 83% under paper-based IMCI compared to 91%
under eIMCI (p < 0.001) [14]. In Afghanistan, only 35%
of children received a treatment in line with HCWs’
classifications at baseline compared to 99% after 1 year
of implementation [17]. Reduction in over-prescriptions
of antibiotic have also been reported using eIMCI in
Afghanistan [17] and Tanzania [15].
In Burkina Faso, interviews with HCWs indicated that
IeDA was well accepted, in particular with respect to the
usefulness of the eCDSS in guiding through the clinical
assessment (Blanchet K et al.: Realist evaluation of the
Integrated electronic Diagnostic Approach (IeDA) for
the management of childhood illness at primary health
facilities in Burkina Faso, submitted). In Ghana, South
Africa and Tanzania, HCWs reported similar opinions
[13, 16]. Nevertheless, our realistic evaluation in Burkina
Faso also revealed contextual factors that may have lim-
ited the effect of the IeDA intervention. First, staff turn-
over was reported to be common by district managers,
in particular in remote rural facilities where most HCWs
do not want to spend more than a few years. A visit in
July 2017 in all intervention facilities revealed that
around a third of HCWs (36%) had been changed within
the last 12 months and that a relatively large proportion
(36%) of HCWs had not benefited from the eIMCI train-
ing (Blanchet K et al.: Realist evaluation of the Integrated
electronic Diagnostic Approach (IeDA) for the manage-
ment of childhood illness at primary health facilities in
Burkina Faso, submitted). Second, while supervision and
audit with feedback can be effective in improving per-
formance [28–30], monthly supervision visits planned
under the IeDA intervention in Burkina Faso faced chal-
lenges. The district management teams reported limited
budget, access to vehicles and time to dedicate to these
visits (Blanchet K et al.: Realist evaluation of the Inte-
grated electronic Diagnostic Approach (IeDA) for the
management of childhood illness at primary health facil-
ities in Burkina Faso, submitted).
In addition to incomplete coverage of the IeDA inter-
vention, while pressure from children’s caretakers, some-
times reported during interviews with HCWs (Blanchet
K et al.: Realist evaluation of the Integrated electronic
Diagnostic Approach (IeDA) for the management of
childhood illness at primary health facilities in Burkina
Faso, submitted), may have limited the reduction in
over-prescription of antibiotics, the relatively lower
availability of some essential medicines, such as amoxi-
cillin and ORS, in the intervention facilities compared to
the control facilities may have limited improvement in
correct prescriptions for pneumonia, severe acute mal-
nutrition without complications and diarrhoea. Multiple
conditions may also have influenced the medicines pre-
scribed. Across baseline and trial arms, about a third or
more of children were diagnosed with two or more clas-
sifications. In Tanzania, a large know-do gap was ob-
served, and a lack of knowledge was not the only
constraint identified for improved performance. HCWs’
weak belief in the importance of following guidelines
and confidence in their own experience, lack of intrinsic
motivation, and physical or cognitive “overload” were
also reported, with poor remuneration contributing to
several of these factors [31].
Limitations
Some limitations of our evaluation should be acknowl-
edged. First, the “gold standard” classifications were
provided by a repeat consultation after the initial con-
sultation and it is possible that the clinical status of
some children (e.g. respiratory rate, temperature, current
convulsions) may have changed in the interval between
the two. Therefore, we should not expect full agreement
between HCWs and validation nurses. Our “gold stand-
ard” is certainly less than perfect, and this would tend to
reduce the apparent magnitude of any improvement in
classifications.
Second, it is likely that the behaviour of HCWs was
impacted by the fact that they were observed [32]. The
high proportion of HCWs observed using IMCI paper-
forms in the control districts (68% overall) compared to
routine practice (less than 8% of under-five consultations
in 2012 [33]) suggests that HCWs in this arm were mo-
tivated to perform better than usual. Even if HCWs in
the control districts who used IMCI paper-forms did not
seem to have performed better compared to those who
did not use IMCI paper-forms, repeated observations
might explain improvements in some indicators from
baseline to control steps, for instance adherence to as-
sessment of danger signs (18% at baseline compared to
34% during control steps). Nevertheless, the behaviour
of HCWs in the intervention districts may also have
been affected by the presence of observers. Therefore,
our findings may over-estimate how well HCWs perform
in the absence of an observer, but it is difficult to assert
whether or in which direction this may have affected the
comparison of intervention and control districts.
Third, the initial evaluation design was not followed.
In particular, rolling out the intervention to all districts
as planned would have led to more data in the interven-
tion arm, which could have strengthen our findings. In
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addition, the evaluation design could not address the
multi-faceted nature of the intervention and evolving
version of the eCDSS. It is therefore not possible to dis-
tinguish which component of the intervention led to ob-
served improvements or whether improvements were
the result of the combination of components.
Lastly, with respect to statistical analyses, multiple
comparisons between arms were performed and can
increase the overall error in hypothesis testing, so that
P-values should be interpreted with caution. The small
number of clusters per trial arm precluded using ran-
dom effects models on individual level data, thus limit-
ing our ability to control for individual child-level
factors.
Conclusion
To conclude, the IeDA intervention was well accepted
and improved substantially HCW’s adherence to IMCI
clinical assessment which led to some improvements in
overall correct classifications but little or no improve-
ment in overall correct prescriptions. Nevertheless,
substantial improvements were observed in correct clas-
sifications and prescriptions for dysentery and malnutri-
tion. To some degree, we also observed an improvement
in danger sign identification, correct referrals/hospitali-
sations and management of severe malaria, although
small numbers prevent firm conclusions. For the most
common conditions, HCWs in the control districts, who
may have been influenced by a Hawthorne effect, per-
formed relatively well, limiting the scope to detect an
overall impact.
HCWs’ practices are complex behaviours that have
many potential contextual and intrinsic influences.
Lower availability of some essential medicines in the
intervention districts was observed and our realistic
evaluation concurrently reported staff turnover and in-
complete coverage of training and supervision which
may have limited the effect of the IeDA intervention on
correct classification and prescription. Task adherence
may be easier to achieve than correct classifications
which require clinical skills. In the context of national
scaling up, disparities between regions exist in terms of
structures, staff and resources. Nevertheless, complete
coverage of the eIMCI training could be achieved by its
integration into the initial nursing curriculum. Supervi-
sion will inevitably require resources but also manage-
ment capacity to deal with relationships, organisation
culture and HCWs’ professional norms, experiences and
motivation (Blanchet K et al.: Realist evaluation of the
Integrated electronic Diagnostic Approach (IeDA) for
the management of childhood illness at primary health
facilities in Burkina Faso, submitted).
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